Sign in Create account

Dr. Agarwal's Health Care Limited

Healthcare · Healthcare Services

NSE: AGARWALEYE BSE: 544350
₹484.25
▼ -2.20 (-0.45%)
Oct. 5, 2026 · NSE · nse_bhavcopy
Quality
47/100
Moderate
Valuation
—/100
Expensive
Momentum
30/100
Bearish

QVM read Mixed signals Quality Moderate, Valuation Expensive, Momentum Bearish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹15,350 Cr
PE (TTM)
334.0
Industry median 48.2 (44 companies)
Price to Book
7.2
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
65.68%
FII + DII, latest filed period
Piotroski Score
6
Relative return vs Nifty50, qtr %
8.1
Relative return vs Sector, qtr %
6.3
Free Cash Flow
₹71 Cr
as of March 31, 2026
Industry median ₹1 Cr (75 companies)
EPS Growth (YoY)
65.63%
as of June 30, 2026
Industry median 13.27% (57 companies)
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
64.89%
as of June 30, 2026
Industry median 8.53% (57 companies)
Revenue Growth (YoY)
26.81%
as of June 30, 2026
Industry median 18.84% (52 companies)
Current Ratio
1.24
as of March 31, 2026
Industry median 2.06 (74 companies)
Debt to Equity
0.07
as of March 31, 2026
Industry median 0.11 (62 companies)
Interest Coverage
1.98
as of June 30, 2026
Industry median 7.94 (57 companies)
Net Margin
4.36%
as of June 30, 2026
Industry median 9.88% (61 companies)
Operating Margin (EBIT)
10.84%
as of June 30, 2026
Industry median 17.21% (61 companies)
Operating Margin (TTM)
10.45%
as of June 30, 2026
Industry median 16.20% (59 companies)
Return on Assets
4.27%
as of March 31, 2026
Industry median 5.40% (58 companies)
Return on Capital Employed
9.74%
as of March 31, 2026
Industry median 10.44% (56 companies)
Return on Equity
7.93%
as of March 31, 2026
Industry median 10.16% (58 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 6 met
  • No Quality score is Strong (70 or more)
  • No Piotroski F-score is 7 or more (score 6)
  • Yes Debt to equity is below 0.5 (0.07)
  • No Return on equity is 15% or more (7.9%)
  • No Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

2 of 3 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • No Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

3 of 3 met
  • Yes 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

0 of 6 met
  • No Price sits in the Buy zone of its own historical PE range (Overvalued (above its own historical PE range))
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-0.5%
Low 475.3000 · High 492.0000
1W return
-3.8%
Low 471.1500 · High 501.9500
1M return
-5.8%
Low 471.1500 · High 528.8000
52W return
-1.3%
Low 401.0000 · High 568.0000
Lifetime High ₹560.7000 (Aug. 10, 2026)
Lifetime Low ₹334.0500 (June 2, 2025)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish1
Bearish5
5D
488.3
10D
492.6
20D
497.3
50D
497.5
100D
489.6
200D
472.1

Delivery and volume

Day avg. delivery
61.1%
Week avg. delivery
51.6%
Month avg. delivery
56.4%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

483.85
Pivot
First resistance492.40
Second resistance500.55
Third resistance509.10
First support475.70
Second support467.15
Third support459.00
Day RSI39.8
Day MFI39.3
Day MACD-4.73
Day MACD signal-2.57

Beta

1M-0.44
3M-0.09
1Y0.28
3Y0.29

Price change analysis

↓ -5.8%
Over 1 Month
LowHigh
471.15528.80
↑ 0.6%
Over 3 Months
LowHigh
463.00567.75
↑ 12.6%
Over 6 Months
LowHigh
418.90567.75
↓ -1.3%
Over 1 Year
LowHigh
401.00568.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 334.0 (own history: 288.8–330.3)
Overvalued (above its own historical PE range)

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹383 Cr
Net profit (June 30, 2026)
₹17 Cr
Basic EPS (June 30, 2026)
₹0.5300

Ranks #9 of 62 in Healthcare Services by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter32.34%
  • Mutual funds6.02%
  • FII/FPI57.96%
  • Other DII1.70%
  • Public1.98%

Largest holders

NameCategoryShares %Shares
HYPERION INVESTMENTS PTE. LTD.Public23.0900%73193988
CLAYMORE INVESTMENTS (MAURITIUS) PTE. LTDPublic10.1900%32296300
ARVON INVESTMENTS PTE.LTD.Public9.8700%31275470
GOVERNMENT OF SINGAPOREPublic6.3500%20135130
ATHIYA AGARWALPromoter4.4500%14103543

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings decreased from 32.36% to 32.34% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings increased from 57.94% to 57.96% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings increased from 5.87% to 6.02% in Jun 2026 qtr

16 mutual fund schemes also hold this stock.

All shareholding details →

Insider trading, SAST & pledges

All 0 insider trades, 25 SAST, 0 pledge events →

All insider and SAST disclosures →

Deals (Bulk & Block)

All 16 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
12 Aug 2026 POLAR CAPITAL FUNDS PLC-HEALTHCARE OPPORTUNITIES FUND Bulk Buy 3,626,410 501.0000 NSE
12 Aug 2026 MARWADI CHANDARANA INTERMEDIARIES BROKERS PRIVATE LIMITED Bulk Buy 1,959,808 502.4600 NSE
12 Aug 2026 MARWADI CHANDARANA INTERMEDIARIES BROKERS PRIVATE LIMITED Bulk Sell 650,808 510.9600 NSE
12 Aug 2026 INVESCO MUTUAL FUND Bulk Buy 3,565,443 504.6400 NSE
12 Aug 2026 ICICI PRUDENTIAL MUTUAL FUND Bulk Buy 6,211,813 501.0000 NSE
12 Aug 2026 HYPERION INVESTMENTS PTE. LTD. Bulk Sell 24,160,000 501.0300 NSE
12 Aug 2026 CLAYMORE INVESTMENTS (MAURITIUS) PTE.LTD. Bulk Sell 15,900,000 501.5400 NSE
12 Aug 2026 ALLIANZ GLOBAL INVESTORS GMBH ACTING ON BEHALF OF ALLIANZ EEE FONDS Bulk Buy 1,772,127 501.0000 NSE
2 Sep 2025 GOLDMAN SACHS BANK EUROPE SE- ODI Block Buy 1,653,725 433.2500 NSE
2 Sep 2025 GOLDMAN SACHS (SINGAPORE) PTE - ODI Block Sell 1,653,725 433.2500 NSE

All bulk and block deals →

Board Meetings

View board meeting history →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
4 Aug 2026 Financial Results Yes
21 May 2026 Financial Results Yes
3 Feb 2026 Financial Results Yes
30 Oct 2025 Financial Results Yes
12 Aug 2025 Financial Results Yes

Corporate Announcements

All 153 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
29 Sep 2026 General Updates Update on step-down wholly owned subsidiary in Nigeria by Orbit Healthcare Services (Mauritius) Limited, a direct wholly owned subsidiary of the Company.
29 Sep 2026 Cessation Dr. Agarwal's Health Care Limited has informed the Exchange regarding Cessation of Mr. Sanjay Anand as Non- Executive Independent Director of the company w.e.f. September 29, 2026.
29 Sep 2026 Company Update Dr. Agarwals Health Care Ltd - 544350 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
29 Sep 2026 Company Update Dr. Agarwals Health Care Ltd - 544350 - Announcement under Regulation 30 (LODR)-Cessation
28 Sep 2026 Insider Trading / SAST Dr. Agarwals Health Care Ltd - 544350 - Closure of Trading Window
28 Sep 2026 Trading Window Dr. Agarwal's Health Care Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
21 Sep 2026 Shareholders meeting Voting Results and Consolidated Scrutinizer s Report of the 16th Annual General Meeting ("AGM") of Dr. Agarwal s Health Care Limited
21 Sep 2026 Shareholders meeting Proceedings of the 16th Annual General Meeting ("AGM") of Dr. Agarwal's Health Care Limited held on Monday, September 21, 2026, is submitted
21 Sep 2026 AGM/EGM Dr. Agarwals Health Care Ltd - 544350 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
21 Sep 2026 AGM/EGM Dr. Agarwals Health Care Ltd - 544350 - Shareholder Meeting / Postal Ballot-Outcome of AGM

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.07)
  • Strong revenue growth YoY (26.8%)

Weaknesses

  • Low Return on Equity (7.9%)
  • Thin net profit margin (4.4%)

Opportunities

Data unavailable.

Threats

  • PE above 35 (334.0) -- priced for continued strong execution
  • Weak interest coverage (2.0x) -- limited cushion against rising rates

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Dr. Agarwal's Health Care Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.